With the stock currently trading at Rs 1,954.90, Gland Pharma faces a challenging trading environment amidst early market volatility.

The move reflects a broader recalibration by BofA analysts, who are adjusting their models to account for changes in market ...

The move follows strong industry data pointing to robust cruise demand and pricing trends holding firm through the second ...

Nifty50 and BSE Sensex, the Indian equity benchmark indices, opened flat in trade on Monday. While Nifty50 was near 24,950, BSE Se ...

Oscar's strong revenue growth, improving profitability, and efficient SG&A management support my positive outlook. Read why ...

IUSV provides broad diversification across large- and mid-cap value stocks, with a more attractive valuation than ...

U.S. stock index futures remained largely flat Sunday evening as investors braced for a wave of second-quarter earnings ...

Trade Brains Portal is a stock analysis platform. Its trade name is Dailyraven Technologies Pvt. Ltd, and its Sebi-registered research analyst registration number is INH000015729. Investments in ...

Artificial intelligence (AI) investing remains at the forefront of the market as companies continue to invest billions of ...

In fact, oil prices and the stock market may rise together. Orman recalled 2006 and 2007, when oil prices surged and the S&P ...

Nebius had an interesting path to relevancy in the AI realm. The company listed on the Nasdaq Stock Market in late 2024 ...

Taiwan Semiconductor (TSMC) has surged over 300% from its 2022 low, driven by record-breaking earnings and soaring demand for ...